O

Option Care Health

Largest independent home infusion therapy provider

Clinical Pharmacist

Full-TimeUpdated on 10/23/2026
$120.8k - $201.3k+ 401(k) Company Match + HSA Company Match
Entry
Bachelor's
Farmington Hills, MI, USA
In PersonWillingness to travel up to 5% within the state.
Medical, Clinical & VeterinaryPharmacy

About the job

Requirements
  • Graduate of an accredited School of Pharmacy.
  • Hold a current, active pharmacy license granted by the State Board of Pharmacy.
  • Meet one of the following: at least one year of experience in sterile IV admixture procedures; knowledge of non-sterile compounding, immunizations, and medication therapy management; completion of an ASHP-accredited Pharmacy Residency Program; completion of an Advanced Pharmacy Practice Experience associated with an accredited school of pharmacy; or equivalent experience approved by the Vice President of Pharmacy and/or Senior Vice President of Clinical Services.
  • Have experience providing customer service to internal and external customers, including meeting service quality standards and evaluating customer satisfaction.
  • Have basic Microsoft Word skills, including opening documents; cutting, pasting, and aligning text; selecting font type and size; changing margins and column width; sorting; inserting bullets, pictures, and dates; using find and replace, undo, spell check, track changes, review pane, and print functions.
  • Have basic Microsoft Excel skills, including opening workbooks; inserting rows and columns; selecting font style and size; formatting cells as currency; copying, pasting, and saving; aligning text; selecting cells; renaming worksheets; selecting chart styles; inserting worksheets; setting margins and page orientation; using spell check; and printing worksheets.
  • Have basic Microsoft PowerPoint skills, including inserting, rearranging, hiding, and deleting slides; navigating slides; increasing list level; adding, centering, and editing text; changing views; inserting tables or notes; moving objects; printing outline view; and running slide shows.
  • Have at least one year of experience in indirect management of team members, including assisting with their development, training, and assignment of work or projects.
  • Be willing to travel up to 5% of the time for business purposes within the state.
Responsibilities
  • Determine whether individual patients are suitable for home care by collecting and organizing patient-specific information and assessing their medical condition, prescribed medication therapy, prognosis, and clearly defined outcome goals in accordance with company policies.
  • Design, recommend, monitor, and evaluate patient-specific pharmacy care plans for home-care pharmacotherapy; recommend changes to prescribed medication therapy or monitoring parameters when appropriate; collect and organize information to prevent, detect, and resolve medication-related problems; identify appropriate monitoring parameters; and complete nutritional assessments with recommendations.
  • Modify home-care pharmacy care plans based on monitoring data and other relevant patient-specific information; apply pharmacokinetic principles and formulas; and assess patient laboratory values.
  • Educate company staff, other professionals, home-care patients, and caregivers about medication use, and counsel patients and caregivers using effective patient education techniques.
  • Ensure continuity of pharmaceutical care between home and other care settings by communicating pertinent patient information systematically; prepare and dispense medications using appropriate techniques and company procedures; calibrate equipment; prepare medications to appropriate concentrations, free from incompatibilities, stable, and stored appropriately; follow safety and quality assurance practices; prepare compliant labels and ancillary labels; inspect final medications; verify authorization to dispense; comply with state and federal laws and USP standards, including controlled-substance regulations; and follow perpetual inventory policies for Schedule II narcotics, controlled substances, and other medications subject to diversion.
  • Manage the use, maintenance, and troubleshooting of medication administration and related equipment used for home-care patients; program and maintain equipment accurately and advise others on its use and maintenance; participate in assessing, managing, and reporting medication-related incidents and equipment errors or failures; complete QAR documents according to company policy; and monitor and report perpetual-inventory discrepancies involving Schedule II narcotics and other medications subject to diversion.
  • Respond concisely, appropriately, and promptly to drug-information requests from healthcare providers and home-care patients; formulate responses based on literature analysis; and attend educational seminars or other continuing education opportunities to maintain professional competency and meet state-mandated continuing education requirements.
  • Manage investigational drug products according to applicable regulations and company policies and procedures; use pharmacy support personnel effectively; prioritize and organize workflow according to available resources; ensure needed work is completed within available time; and ensure the accuracy of pharmacy support personnel's work.
  • Comply with accreditation, legal, regulatory, and safety requirements in all activities.
  • Maintain confidentiality of patient and proprietary information and follow legal and ethical guidelines for safeguarding that information.
  • May perform other duties as assigned.
Desired Qualifications
  • Completion of an ASHP-accredited Pharmacy Residency Program or an Advanced Pharmacy Practice Experience associated with an accredited school of pharmacy.
  • Experience in home care, a hospital, or another clean-room setting.

About the company

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Bannockburn, Illinois

Founded

1979

Get referred to Option Care Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 29, 2026 Q2 revenue reached $1.44 billion, while acute therapy and IG Neuro strengthened.
  • Management stabilized CID patient census in Q2 2026 and kept full-year revenue guidance unchanged.
  • The company repurchased $150 million in Q2 2026, signaling confidence and shareholder-return capacity.

What critics are saying

  • August 2026 guidance still bakes in a 600-basis-point CID revenue headwind and $55 million gross profit hit.
  • July 29, 2026 Q2 buyback of $150 million masks weak top-line momentum and analyst skepticism.
  • Biosimilar erosion and payer reverification pressure can permanently shrink chronic volumes if retention stays broken.

What makes Option Care Health unique

  • Option Care Health leads U.S. independent home and alternate-site infusion, with nationwide clinician density.
  • Its payer, biopharma, and prescriber relationships create switching costs across chronic and acute therapies.
  • August 27, 2026 guidance shows durable cash generation, with at least $320 million operating cash flow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Time Off
  • Bonding Time Off
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Health Savings Account/Flexible Spending Account
  • Flexible Spending Accounts
  • Tuition Reimbursement
  • Family Support
  • Mental Health Support

Company News

AD HOC NEWS
Oct 15th, 2026
McKesson commits $1.4B for 49% stake in Option Care at $5.8B valuation

McKesson will invest $1.4 billion for a 49% minority stake in Option Care Health, under an agreement announced on October 6, 2026. The deal values Option Care at an enterprise value of $5.8 billion. Clayton, Dubilier & Rice will hold about 51%. Option Care will stay separately managed, while McKesson keeps a framework to acquire the remaining interest later, subject to conditions and regulatory approvals. In its first fiscal 2027 quarter, McKesson reported revenue of $105.38 billion, up 7.7% year on year, and adjusted earnings per share of $9.93. It will report second-quarter results on November 4, 2026.

Yahoo Finance
Oct 6th, 2026
McKesson and Clayton Dubilier & Rice near $5B deal to acquire Option Care Health

Option Care Health shares jumped 33.2% in pre-market trading after the Financial Times reported McKesson and Clayton Dubilier & Rice are nearing a transaction valued at over $5 billion to acquire the alternate site health provider. According to the report, the deal would involve the two firms partnering to buy the infusion services provider, which they view as undervalued. Large-scale buyout discussions typically drive market optimism as investors anticipate acquisition premiums. The move is significant for Option Care Health, whose shares have experienced 13 movements greater than 5% over the past year. At $31.03 per share, the stock is trading 15.2% below its 52-week high but remains down 3.8% year-to-date.

Central Charts
Oct 6th, 2026
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have

Yahoo Finance
Jul 29th, 2026
Option Care Health Q2 beats expectations with $1.4B revenue, narrows full-year guidance

Option Care Health reported second-quarter 2026 results that exceeded expectations. Revenue rose 7% sequentially to $1.4 billion, whilst adjusted EBITDA increased 12% to $117.5 million and adjusted EPS reached $0.45. Operating cash flow totalled $184 million. Acute therapies posted high-single-digit organic growth, while chronic revenue improved sequentially as the CID portfolio began to stabilise. However, CID-related pressure is expected to reduce 2026 revenue by roughly 600 basis points and gross profit by $55 million. The home and alternate-site infusion provider maintained its full-year revenue guidance at $5.675 billion to $5.775 billion. Adjusted EBITDA guidance was narrowed to $480 million to $495 million, and adjusted EPS guidance to $1.85 to $1.92. The company repurchased $150 million of shares, nearly 5% of shares outstanding.

Yahoo Finance
Jul 29th, 2026
Option Care Health reports $1.44B Q2 revenue, up 1.9%, and raises $150M share buyback

Option Care Health, the largest independent provider of home and alternate site infusion services in the US, reported second quarter 2026 results. Net revenue reached $1.44 billion, up 1.9% year-over-year. The company posted net income of $53.9 million, up 6.7%, with diluted earnings per share of $0.35, up 12.9%. Adjusted EBITDA grew 3.0% to $117.5 million. The company repurchased $150 million of outstanding shares during the quarter. For full year 2026, Option Care Health expects net revenue between $5.68 billion and $5.78 billion, with adjusted diluted earnings per share of $1.85 to $1.92. The company forecasts adjusted EBITDA of $480 million to $495 million and operating cash flow of at least $320 million.